ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
JBeez_
|
146 |
39K |
31 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
39K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
JBeez_
|
38 |
7.3K |
5 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.3K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
JBeez_
|
38 |
7.3K |
6 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.3K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
JBeez_
|
146 |
39K |
13 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
39K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JBeez_
|
391 |
74K |
38 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
74K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JBeez_
|
391 |
74K |
23 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
74K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
JBeez_
|
391 |
74K |
24 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
74K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
JBeez_
|
80 |
24K |
49 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
24K
|
49
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
JBeez_
|
2.9K |
1.0M |
10 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
JBeez_
|
2.9K |
1.0M |
32 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
32
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
JBeez_
|
2.2K |
756K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.2K
|
756K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
JBeez_
|
80 |
25K |
31 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
80
|
25K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
JBeez_
|
1.8K |
639K |
72 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.8K
|
639K
|
72
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
JBeez_
|
80 |
25K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
JBeez_
|
80 |
25K |
5 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
JBeez_
|
80 |
25K |
52 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
52
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JBeez_
|
21K |
7.4M |
41 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Is RAC undervalued? the rNPV says...
|
|
JBeez_
|
4 |
2.0K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
4
|
2.0K
|
4
|
|
ASX - By Stock
|
RAC |
Is RAC undervalued? the rNPV says...
|
|
JBeez_
|
4 |
2.0K |
51 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
4
|
2.0K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
JBeez_
|
1.0K |
300K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
300K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
JBeez_
|
1.0K |
300K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
300K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JBeez_
|
662 |
204K |
10 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
662
|
204K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
JBeez_
|
37 |
8.9K |
22 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
37
|
8.9K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
JBeez_
|
37 |
8.9K |
46 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
37
|
8.9K
|
46
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
JBeez_
|
152 |
63K |
18 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
63K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
JBeez_
|
55 |
16K |
54 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
16K
|
54
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JBeez_
|
21K |
7.4M |
33 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JBeez_
|
662 |
204K |
17 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
662
|
204K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
JBeez_
|
194 |
79K |
16 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
194
|
79K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JBeez_
|
662 |
204K |
27 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
662
|
204K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JBeez_
|
662 |
204K |
45 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
662
|
204K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
JBeez_
|
662 |
204K |
113 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
662
|
204K
|
113
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JBeez_
|
21K |
7.4M |
77 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
21K
|
7.4M
|
77
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4D & Half-Year Financial Statements
|
|
JBeez_
|
57 |
15K |
17 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
57
|
15K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
JBeez_
|
1.0K |
300K |
15 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
1.0K
|
300K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
JBeez_
|
1.8K |
639K |
19 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
1.8K
|
639K
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
JBeez_
|
11K |
3.9M |
51 |
14/02/24 |
14/02/24 |
General
|
11K
|
3.9M
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
JBeez_
|
1.8K |
639K |
50 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
1.8K
|
639K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
47 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
128K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
41 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
128K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
14 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
128K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
10 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
22 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
9 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
30 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
43 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
44 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
42 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JBeez_
|
508 |
128K |
50 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
128K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
JBeez_
|
96 |
26K |
28 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
96
|
26K
|
28
|
|